Palo Alto – March 8, 2021 – Cooley advised Venrock on the closing of its ninth fund at $450 million. The fund will enable the venture capital firm to continue its mission to invest in early-stage technology and healthcare businesses that are taking novel approaches to solving important problems. Lawyers John Clendenin and Casey Schulte led the Cooley team advising Venrock.
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies include Apple Computer, Athenahealth, Centocor, Check Point Software, Dollar Shave Club, DoubleClick, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel and Nest.
Cooley has advised Venrock on a range of matters, including its fund formations and investments, since 2003.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.